Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |